Anavex Life Sciences Corp.
AVXL
$11.20
-$0.10-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 115.77M | 120.78M | 132.19M | 138.76M | 139.39M |
| Total Receivables | 666.00K | 2.56M | 2.45M | 1.72M | 3.79M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 702.00K | 711.00K | 931.00K | 1.06M | 1.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 117.14M | 124.04M | 135.57M | 141.54M | 144.52M |
|
|
|||||
| Total Current Assets | 117.14M | 124.04M | 135.57M | 141.54M | 144.52M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 117.14M | 124.04M | 135.57M | 141.54M | 144.52M |
|
|
|||||
| Total Accounts Payable | 7.00M | 4.57M | 9.63M | 3.50M | 3.73M |
| Total Accrued Expenses | 9.56M | 7.73M | 4.84M | 7.33M | 4.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 829.00K | 829.00K | 842.00K | 917.00K | 917.00K |
| Total Other Current Liabilities | 829.00K | 829.00K | 842.00K | 917.00K | 917.00K |
| Total Current Liabilities | 17.38M | 13.13M | 15.30M | 11.75M | 9.56M |
|
|
|||||
| Total Current Liabilities | 17.38M | 13.13M | 15.30M | 11.75M | 9.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.38M | 13.13M | 15.30M | 11.75M | 9.56M |
|
|
|||||
| Common Stock & APIC | 459.14M | 459.10M | 456.33M | 454.32M | 447.43M |
| Retained Earnings | -359.38M | -348.18M | -336.07M | -324.45M | -312.24M |
| Treasury Stock & Other | -- | -- | -- | -89.00K | -234.00K |
| Total Common Equity | 99.76M | 110.92M | 120.26M | 129.78M | 134.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 99.76M | 110.92M | 120.26M | 129.78M | 134.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 99.76M | 110.92M | 120.26M | 129.78M | 134.96M |
|
|
|||||